Saturday, October 31, 2026

Aphria Stock Bullish By 2% So Far On Wednesday

ViaNews Editorial Team

December 16, 2020

Aphria Stock Bullish By 2% So Far On Wednesday

Shares of Aphria jumped 2.65% to $8.34 at 12:55 EST on Wednesday, following yesterday's upward trend. The Nasdaq Stock Market is rising 0.36% to $12,640.70, after two consecutive sessions in a row of gains. This seems, up to now, a somewhat positive trend trading session today.

Aphria's last close was $8.12, 6.47% below its 52-week high of $8.88.

News about Aphria today

Aphria, tilray announce deal to create biggest cannabis company. According to today's article on Bloomberg Quint, "The new company will trade under Tilray's ticker on the Nasdaq, and Aphria shareholders will own 62% of Tilray's stock under the terms of the transaction, which was characterized as a "reverse acquisition of Tilray." ", "Kennedy said Aphria's two assets in Germany -- a distribution center for medical prescriptions and a cultivation facility -- were particularly attractive."

Tilray stock soars after 'reverse' merger deal with Aphria at a 23% premium. According to today's article on MarketWatch, "Shares of Tilray Inc. soared 30.8% in premarket trading and Aphria Inc.'s U.S.-listed stock surged 9.9%, after the Canada-based cannabis companies announced a merger, which they say will create the largest global cannabis company, with a combined equity value of about $3.9 billion. ", "After the deal closes, which the companies said was structured has a "reverse acquisition" of Tilray, Aphria shareholders will own 62% of outstanding Tilray shares. "

Stocks making the biggest moves in the premarket: tilray, Aphria, penumbra, Moderna & more. According to today's article on CNBC, "Tilray (TLRY), Aphria (APHA) - The Canadian cannabis companies will combine in an all-stock deal that will create the world's biggest cannabis producer. ", "Tilray shares surged 30%, while Aphria shares jumped more than 8% in the premarket."

Aphria's Stock Top and Bottom Yearly Value

Aphria's stock is valued at $8.34 at 12:55 EST, below its 52-week high of $8.88 and way above its 52-week low of $1.95.

Aphria's Moving Average

Aphria's value is way higher than its 50-day moving average of $6.52 and way above its 200-day moving average of $5.15.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com